GlassScriptPhysician profile
Steve K Williams
NPI 1104245158
$19,134.41
in general payments reported to CMS, 2019-2025
44 companies · $1,915 in 2025
The $1,915 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,639 · 2020: $3,098 · 2021: $1,934 · 2022: $3,781 · 2023: $5,498 · 2024: $1,270 · 2025: $1,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,683 · Education: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,682.97 |
| Education | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,088.40 | 2020-2023 | Davinci Xi |
| Teleflex LLC | $2,406.44 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $2,185.86 | 2019-2025 | Ams 700, Lithovue, Spaceoar Vue System - 10ml |
| Smith+Nephew, INC. | $1,610.91 | 2019-2024 | Pico 14 |
| Coloplast Corp | $1,232.67 | 2019-2024 | Titan |
| Procept Biorobotics Corporation | $1,067.00 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Neotract INC. | $889.17 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $782.26 | 2020-2024 | Aveed, Xiaflex |
| Karl Storz Endoscopy-America | $756.26 | 2019-2022 | |
| Calyxo, INC. | $441.53 | 2022-2025 | Cvac Aspiration System |
| Myriad Genetic Laboratories, INC. | $329.24 | 2022-2025 | Prolaris |
| C. R. Bard, INC. & Subsidiaries | $326.93 | 2021 | |
| Pfizer INC. | $262.44 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $261.50 | 2023 | Keytruda, Lynparza, Welireg |
| Allergan, INC. | $253.37 | 2019-2021 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $230.22 | 2022-2025 | Jelmyto |
| Angiodynamics, INC. | $214.97 | 2025 | Nanoknife |
| Antares Pharma, INC. | $185.22 | 2020-2023 | Xyosted, Tlando, Nocdurna |
| Accord Healthcare, INC. | $184.82 | 2022 | |
| Koelis INC. | $157.49 | 2021 | |
| Biowound Solutions, INC. | $156.21 | 2025 | Bio-Connekt |
| Davol INC. | $153.71 | 2023 | Arista Ah Flexitip |
| Endo USA, INC. | $151.05 | 2024 | Xiaflex, Aveed |
| Photocure INC | $146.62 | 2022 | |
| Olympus America INC. | $144.94 | 2022 | |
| Mimedx Group, INC. | $134.56 | 2025 | |
| Ambu INC. | $126.14 | 2020 | |
| Medical Device Business Services, INC. | $125.00 | 2020 | |
| Medtronic USA, INC. | $124.02 | 2020 | |
| Mallinckrodt Enterprises LLC | $120.33 | 2019 | |
| Next Science LLC | $119.05 | 2021 | |
| Abbvie INC. | $117.50 | 2022-2025 | Botox |
| Ferring Pharmaceuticals INC. | $115.29 | 2024 | Adstiladrin |
| Janssen Biotech, INC. | $103.42 | 2023-2024 | Erleada, Akeega |
| Rochester Medical Corporation | $81.30 | 2020 | |
| Integra Lifesciences Corporation | $73.05 | 2023 | Biodoptix, Biofix, Biodrestore |
| Astellas Pharma US INC | $70.66 | 2022-2023 | Myrbetriq |
| Medtronic, INC. | $52.30 | 2023 | Lapro-Clip |
| Astrazeneca Pharmaceuticals LP | $42.28 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $29.19 | 2023 | Orgovyx |
| 180 Medical, INC. | $28.64 | 2024 | Gentlecath |
| Myovant Sciences INC. | $22.18 | 2022 | |
| Amarin Pharma, INC. | $15.34 | 2019 | |
| Currax Pharmaceuticals LLC | $14.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.